PKU: High plasma phenylalanine concentrations are associated with increased prevalence of mood swings

Molecular Genetics and Metabolism

Volumn 104, Issue 3, 2011, Pages 231-234

  Anjema, Karen ^a   van Rijn, Margreet ^a   Verkerk, Paul H ^b   Burgerhof, Johannes G M ^c   Heiner Fokkema, M Rebecca ^c   van Spronsen, Francjan J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b TNO   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Behavior; Mood; Mood swings; Phenylalanine; Phenylketonuria; PKU

Indexed keywords

PHENYLALANINE;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENVIRONMENT; HUMAN; HYPERACTIVITY; INFANT; INTERVIEW; MOOD CHANGE; PHENYLKETONURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; LIKELIHOOD FUNCTIONS; MOOD DISORDERS; PHENYLALANINE; PHENYLKETONURIAS; QUESTIONNAIRES;

EID: 82455188023     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.05.017     Document Type: Article

References (15)

1. Blau N., van Spronsen F.J., Levy H.L. Phenylketonuria. Lancet 2010, 376:1417-1427.
2. Smith I., Beasley M.G., Ades A.E. Intelligence and quality of dietary treatment in phenylketonuria. Arch. Dis. Child. 1990, 65:472-478.
3. Smith I., Beasley M.G., Ades A.E. Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria. Arch. Dis. Child. 1991, 66:311-316.
4. Burgard P. Development of intelligence in early treated phenylketonuria. Eur. J. Pediatr. 2000, 159(Suppl. 2):S74-S79.
5. Lundstedt G., Johansson A., Melin L., Alm J. Adjustment and intelligence among children with phenylketonuria in Sweden. Acta Paediatr. 2001, 90:1147-1152.
6. Verkerk P.H. 20-year national screening for phenylketonuria in The Netherlands. National Guidance Commission PKU. Ned. Tijdschr. Geneeskd. 1995, 139:2302-2305.
7. Gassio R., Fuste E., Lopez-Sala A., Artuch R., Vilaseca M.A., Campistol J. School performance in early and continuously treated phenylketonuria. Pediatr. Neurol. 2005, 33:267-271.
8. Christ S.E., Huijbregts S.C., de Sonneville L.M., White D.A. Executive function in early-treated phenylketonuria: profile and underlying mechanisms. Mol. Genet. Metab. 2010, 99(Suppl. 1):S22-S32.
9. Smith I., Beasley M.G., Wolff O.H., Ades A.E. Behavior disturbance in 8-year-old children with early treated phenylketonuria. Report from the MRC/DHSS Phenylketonuria Register. J. Pediatr. 1988, 112:403-408.
10. Weglage J., Funders B., Wilken B., Schubert D., Schmidt E., Burgard P., Ullrich K. Psychological and social findings in adolescents with phenylketonuria. Eur. J. Pediatr. 1992, 151:522-525.
11. Pietz J., Fatkenheuer B., Burgard P., Armbruster M., Esser G., Schmidt H. Psychiatric disorders in adult patients with early-treated phenylketonuria. Pediatrics 1997, 99:345-350.
12. ten Hoedt A.E., de Sonneville L.M., Francois B., ter Horst N.M., Janssen M.C., Rubio-Gozalbo M.E., Wijburg F.A., Hollak C.E., Bosch A.M. High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial. J. Inherit. Metab. Dis. 2011, 34:165-171.
13. Fitzgerald B., Morgan J., Keene N., Rollinson R., Hodgson A., Dalrymple-Smith J. An investigation into diet treatment for adults with previously untreated phenylketonuria and severe intellectual disability. J. Intellect. Disabil. Res. 2000, 44(Pt. 1):53-59.
14. Stemerdink B.A., Kalverboer A.F., van der Meere J.J., van der Molen M.W., Huisman J., de Jong L.W., Slijper F.M., Verkerk P.H., van Spronsen F.J. Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J. Inherit. Metab. Dis. 2000, 23:548-562.
15. Antshel K.M., Waisbren S.E. Developmental timing of exposure to elevated levels of phenylalanine is associated with ADHD symptom expression. J. Abnorm. Child Psychol. 2003, 31:565-574.